Rosiglitazone Clinical Trials

• Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
  ClinicalTrials.gov Identifier: NCT00499707 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Rosiglitazone Plaque Study
  ClinicalTrials.gov Identifier: NCT00123227 - Active, not recruiting
  Diabetes Mellitus, Type 2; Vascular Diseases; Hypertension
  
• Rosiglitazone in Treating Patients With Liposarcoma
  ClinicalTrials.gov Identifier: NCT00004180 - Active, not recruiting
  adult liposarcoma; recurrent adult soft tissue sarcoma
  
• Rosiglitazone-Induced Weight Gain
  ClinicalTrials.gov Identifier: NCT00225225 - Recruiting
  Type 2 Diabetes Mellitus
  
• The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial
  ClinicalTrials.gov Identifier: NCT00095654 - Active, not recruiting
  Impaired Glucose Tolerance; Cardiovascular Disease; Glucose Metabolism Disorders
  
• Rosiglitazone Versus Placebo in Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00225355 - Recruiting
  Angina Pectoris; Metabolic Syndrome X
  
• Rosiglitazone versus Glipizide on Progression of Atherosclerosis in Patients with Cardiovascular Disease and Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00116831 - Recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
  ClinicalTrials.gov Identifier: NCT00143624 - Recruiting
  HIV Metabolic Syndrome; Atherosclerosis in HIV
  
• Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
  ClinicalTrials.gov Identifier: NCT00337350 - Active, not recruiting
  Schizophrenia
  
• The Influence of Rosiglitazone on the Diuretic Effect of Furosemide and Amiloride
  ClinicalTrials.gov Identifier: NCT00285805 - Active, not recruiting
  Insulin Resistance
  
• Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
  ClinicalTrials.gov Identifier: NCT00424762 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• The Study of Atherosclerosis with Ramipril and Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00140647 - Active, not recruiting
  Atherosclerosis; Impaired Glucose Tolerance; isolated impaired fasting glucose; Cardiovascular Disease
  
• An Evaluation of Exenatide and Rosiglitazone in Subjects with Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00135330 - Recruiting
  Diabetes Mellitus, Type 2
  
• Rosiglitazone and Mild Cognitive Impairment (MCI)
  ClinicalTrials.gov Identifier: NCT00242593 - Recruiting
  Mild Cognitive Impairment
  
• RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
  ClinicalTrials.gov Identifier: NCT00379769 - Active, not recruiting
  Type 2 Diabetes
  
• Rosiglitazone Effect on Mitochondria and Lipoatrophy
  ClinicalTrials.gov Identifier: NCT00367744 - Recruiting
  HIV Infections
  
• Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics with Angina
  ClinicalTrials.gov Identifier: NCT00225342 - Not yet recruiting
  Angina Pectoris; Diabetes Mellitus, Type 2
  
• Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
  ClinicalTrials.gov Identifier: NCT00169832 - Active, not recruiting
  Diabetes; Coronary Artery Bypass Grafting
  
• Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00364221 - Active, not recruiting
  Metabolic Syndrome; Insulin Resistance
  
• The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00379600 - Active, not recruiting
  Rheumatoid Arthritis
  
• Rosiglitazone on Microalbuminuria in Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00500955 - Active, not recruiting
  Type 2 Diabetes Mellitus; Microalbuminuria
  
• Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels
  ClinicalTrials.gov Identifier: NCT00522470 - Recruiting
  Type 2 Diabetes Mellitus; Obesity
  
• Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182052 - Active, not recruiting
  Adenocarcinoma of the Prostate; Prostate Cancer
  
• Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00098852 - Recruiting
  recurrent thyroid cancer; stage IV follicular thyroid cancer; insular thyroid cancer; stage IV papillary thyroid cancer
  
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
  ClinicalTrials.gov Identifier: NCT00329225 - Active, not recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
  ClinicalTrials.gov Identifier: NCT00349427 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Open-Label Extension Study of Rosiglitazone XR as Adjunctive Therapy in Subjects With Mild-to-Moderate Alzheimer's
  ClinicalTrials.gov Identifier: NCT00490568 - Recruiting
  Alzheimers Disease
  
• Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
  ClinicalTrials.gov Identifier: NCT00551564 - Recruiting
  Healthy; Overweight; Type 2 Diabetes Mellitus
  
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) – The ROSITEL Study
  ClinicalTrials.gov Identifier: NCT00486187 - Recruiting
  Type 2 Diabetes Mellitus
  
• A Lifestyle and Combination Medication Therapy Diabetes Prevention Study
  ClinicalTrials.gov Identifier: NCT00116922 - Active, not recruiting
  Glucose Metabolism Disorder; Diabetes
  
• The Impact of Rosiglitazone on Regression of Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00166803 - Recruiting
  Diabetes Mellitus; Atherosclerosis
  
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00367055 - Active, not recruiting
  Type 2 Diabetes
  
• Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
  ClinicalTrials.gov Identifier: NCT00154011 - Completed
  Healthy subjects
  
• South Danish Diabetes Study
  ClinicalTrials.gov Identifier: NCT00121966 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.
  ClinicalTrials.gov Identifier: NCT00468897 - Recruiting
  Alzheimers Disease
  
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
  ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
  Type 2 diabetes mellitus
  
• Rosiglitazone (Avandia) Vs Placebo for Androgren- Dependent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00139412 - No longer recruiting
  Prostate Cancer
  
• Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00130286 - Recruiting
  HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; Visceral fat accumulation; Fat accumulation; HIV-Associated Metabolic Syndrome
  
• PROVIDENCE: Prevention of Restenosis with Oral Rosiglitazone and the Vision Stent in Diabetics with de novo Coronary Lesions
  ClinicalTrials.gov Identifier: NCT00116792 - Active, not recruiting
  Coronary Artery Disease; Diabetes Mellitus
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00381238 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone and Insulin Resistance in Renally Impaired Patients
  ClinicalTrials.gov Identifier: NCT00452166 - Recruiting
  Chronic Kidney Disease; Insulin Resistance
  
• Brain Imaging Study of Rosiglitazone Efficacy and Safety in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00265148 - Recruiting
  Alzheimer's Disease
  
• Effect of Rosiglitazone on ADMA in Critical Illness
  ClinicalTrials.gov Identifier: NCT00409097 - Recruiting
  Critical Illness; Multiple Organ Failure
  
• Rosiglitazone Versus Theophylline in Asthmatic Smokers
  ClinicalTrials.gov Identifier: NCT00119496 - Completed
  Asthma
  
• Rosiglitazone to Reverse Metabolic Defects in Diabetes
  ClinicalTrials.gov Identifier: NCT00094796 - Active, not recruiting
  Diabetes Mellitus, Type II; Insulin Resistance
  
• The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
  ClinicalTrials.gov Identifier: NCT00511823 - Recruiting
  Postoperative Nausea and Vomiting; Chemotherapy-Induced Nausea and Vomiting
  
• Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
  ClinicalTrials.gov Identifier: NCT00413335 - Recruiting
  Obesity; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus
  
• Vascular Effects of Rosiglitazone Vs. Glyburide
  ClinicalTrials.gov Identifier: NCT00123643 - Completed
  Type 2 Diabetes
  
• Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00149383 - Completed
  Falciparum Malaria
  
• Study of Rosiglitazone XR in Subjects With Mild-to-Moderate Alzheimers
  ClinicalTrials.gov Identifier: NCT00550420 - Not yet recruiting
  Alzheimers Disease
  
• Effects of Three Drugs (Colesevelam HCl, Rosiglitazone, and Sitagliptin) on Control of Blood Glucose and Lipids (e.g., Cholesterol) Will be Examined in Patients With Type 2 Diabetes Whose Blood Glucose is Not Completed Controlled With the Diabetes Drug Me
  ClinicalTrials.gov Identifier: NCT00484419 - Recruiting
  Type 2 Diabetes; Hyperlipidemia
  
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients with Insulin and Fat Abnormalities
  ClinicalTrials.gov Identifier: NCT00015691 - Completed
  HIV Infections; Lipodystrophy; Hyperinsulinemia
  
• Effect of Pioglitazone
  ClinicalTrials.gov Identifier: NCT00232362 - Recruiting
  Type 2 Diabetes Mellitus
  
• Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
  ClinicalTrials.gov Identifier: NCT00343395 - Not yet recruiting
  Coronary Artery Disease
  
• Effect of Rosiglitazone On Peritoneal Cytokines in Women with Endometriosis
  ClinicalTrials.gov Identifier: NCT00121953 - Suspended
  Endometriosis
  
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00324675 - Recruiting
  Type 2 Diabetes; Overt Diabetic Nephropathy
  
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
  ClinicalTrials.gov Identifier: NCT00110851 - Completed
  Type 2 Diabetes Mellitus
  
• Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY)
  ClinicalTrials.gov Identifier: NCT00081328 - Recruiting
  Diabetes Mellitus, Type II
  
• Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
  ClinicalTrials.gov Identifier: NCT00497666 - Not yet recruiting
  Diabetes; Diabetic Nephropathy; Renal Protection
  
• NORDIC: Improving Nitric Oxide-Derived Oxidants Using Rosiglitazone in Non-Diabetic Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00293137 - Not yet recruiting
  Chronic Systolic Heart Failure (Dilated Cardiomyopathy)
  
• Rosiglitazone and exercise training: effects on HIV-infected people with insulin resistance, hypertriglyceridemia, and adipose tissue maldistribution
  ClinicalTrials.gov Identifier: NCT00025753 - Completed
  HIV Infections; Insulin Resistance
  
• A Randomised Trial of Rosiglitazone Versus Metformin Monotherapy in Indigenous Australians With Type 2 Diabetes: Effects on Metabolic and Cardiovascular Parameters
  ClinicalTrials.gov Identifier: NCT00437970 - Not yet recruiting
  Diabetes Mellitus, Type 2
  
• Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia
  ClinicalTrials.gov Identifier: NCT00006493 - Completed
  HIV Infections; Hyperlipidemia
  
• A Randomized Trial of Rosiglitazone for Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00065065 - Completed
  Ulcerative Colitis; Inflammatory Bowel Disease
  
• Use of Rosiglitazone in the Treatment of Endometriosis
  ClinicalTrials.gov Identifier: NCT00115661 - Suspended
  Endometriosis
  
• The Effect of Rosiglitazone on Ischemia-Reperfusion-Injury Using Annexin A5 Scintigraphy.
  ClinicalTrials.gov Identifier: NCT00405015 - Not yet recruiting
  Ischemia-Reperfusion Injury; The Metabolic Syndrome
  
• Therapy with Infergen, Ribavirin, & Avandia in a Group of Insulin Resistant, Chronic Hepatitis C, Genotype 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
  ClinicalTrials.gov Identifier: NCT00207402 - Not yet recruiting
  Hepatitis C
  
• Effect of Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00285142 - Completed
  Healthy
  
• Effect of Adiponectin Genetic Polymorphism on Rosiglitazone Response
  ClinicalTrials.gov Identifier: NCT00501488 - Completed
  Diabetes Mellitus
  
• Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00304993 - Completed
  Metabolic Syndrome X; Insulin Resistance
  
• Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction
  ClinicalTrials.gov Identifier: NCT00300911 - Completed
  Diabetes Mellitus, Type 2
  
• Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women
  ClinicalTrials.gov Identifier: NCT00440375 - Completed
  Type 2 Diabetes Mellitus; Obesity; Menopause
  
• Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
  ClinicalTrials.gov Identifier: NCT00306696 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00362726 - Completed
  HIV Infections
  
• Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
  ClinicalTrials.gov Identifier: NCT00178841 - Completed
  Cutaneous T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome
  
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
  ClinicalTrials.gov Identifier: NCT00084578 - Completed
  stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ...
  
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
  ClinicalTrials.gov Identifier: NCT00279045 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00318656 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00290394 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine v Rosiglitazone as Add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
  ClinicalTrials.gov Identifier: NCT00358124 - Completed
  Type 2 Diabetes Mellitus
  
• Rosiglitazone and Insulin in T1DM Adolescents
  ClinicalTrials.gov Identifier: NCT00372086 - Completed
  Type 1 Diabetes; Puberty: >Tanner 2 Breast Development or Testis >4ml
  
• To Investigate the Effect of Rosiglitazone and Ramipril on Pre-Clinical Vasculopathy in Diabetes and IGT Patients
  ClinicalTrials.gov Identifier: NCT00489229 - Completed
  Diabetes; Impaired Glucose Tolerance
  
• Rosiglitazone in Preventing Oral Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00369174 - Completed
  Head and Neck Cancer; Precancerous/Nonmalignant Condition
  
• Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00402909 - Completed
  Type 2 Diabetes
  
• A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00492700 - Completed
  Non Alcoholic Steatohepatitis
  
• The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00314561 - Completed
  Metabolic Syndrome
  
• Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00306644 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00231387 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00549874 - Completed
  Type 2 Diabetes
  
• Endothelial Dysfunction as a Risk Factor in HIV Study
  ClinicalTrials.gov Identifier: NCT00039663 - Completed
  HIV Infections
  
• Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00309309 - Completed
  Kidney Transplant
  
• Insulin, Neurogenetics and Memory in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00018382 - Completed
  Alzheimer Disease
  
• Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00264251 - Completed
  HIV Infections; Insulin Resistance; Obesity
  
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00399711 - Completed
  Diabetes Mellitus, Type 2
  
• Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00306176 - Completed
  Type II Diabetes Mellitus
  
• Effects of Rosiglitazone on Blood Vessels in Patients with High Blood Pressure and High Cholesterol
  ClinicalTrials.gov Identifier: NCT00006071 - Completed
  Hypercholestrolemia; Hypertension
  
• Rosiglitazone to Treat Patients with Heart Failure and Glucose Intolerance or Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00064727 - Completed
  Congestive Heart Failure